FDA
-
-
-
-
-
-
-
Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine
-
-
-
-
-
-
-
Moderna flu vaccine data published in medical journal
-
-
-
-
-
-
-
Moderna (MRNA) PT Raised to $69 at Piper Sandler
-
-
-
-
-
-
-
Moderna Stock Alert: - Kehoe Law Firm, P.C. Investigating Securities Claims on Behalf of Moderna Investors - MRNA
-
-
-
-
-
-
-
Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine
-
-
-
-
-
-
-
FDA probes deaths likely related to COVID vaccines across age groups
-
-
-
-
-
-
-
Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates
-
327,796 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

